Calmodulin Gene Mutations in Patients With Ventricular Arrhythmia of Unknown Origin - A Screening Study

Region Örebro County

Status: Withdrawn

Conditions: Ventricular Tachycardia

Study type: Observational

Funder types: Other

Identifiers

NCT01947543

Protocol no: 2012-11

Details and patient eligibility

About

The aim of this study is to screen a well characterized patient population with ventricular tachycardia of unknown origin and treated with an implantable cardioverter-defibrillator (ICD) for mutations in the calmodulin genes.

Full description

Patients with ventricular tachycardia of unknown origin and treated with an implantable cardioverter-defibrillator (ICD) will be asked to participate in the study. For patients with results showing mutations in the calmodulin genes, family members (parents, siblings and children) will also be asked to participate in the study. For under age patients and relatives who agree to participate, informed consent will also be taken from their custodian.

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients with ventricular tachycardia of unknown origin that have been treated with an ICD
• Signed and dated informed consent

Exclusion criteria

• Inability to provide informed consent

Trial design

0 participants in 2 patient groups

Ventricular tachycardia

Description:

Patients with ventricular tachycardia of unknown origin treated with an ICD.

Family members

Description:

Family members (parents, siblings and children) for patients with results showing mutations in the calmodulin genes.